About LungStage Pro

LungStage Pro is an evidence-based clinical decision-support and educational platform for thoracic oncology, built by Alessandro Maraschi (FRCS, cardiothoracic surgery) for use by qualified healthcare professionals.

What it covers

• IASLC 9th Edition TNM staging (2025)
• Eurolung 1/2, Thoracoscore, RCRI and ThRCRI perioperative risk models
• Predicted post-operative lung function (ppoFEV1 / ppoDLCO)
• Survival estimates (OS / DFS) by stage
• Evidence-based treatment pathways, including neoadjuvant chemo-immunotherapy
• Research analytics and surgical-outcomes benchmarking

Evidence base

Algorithms draw on IASLC, ESTS, ERS, NICE, AIOM, ESMO and NCCN guidance. LungStage Pro is a decision-support and educational tool; it is not a medical device and does not replace multidisciplinary clinical judgement.